These final results, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the idea of targeting ACKR3 as a singular approach to modulate the opioid process, which could open up new therapeutic avenues for opioid-related Issues. “Total, the discovery with https://josepht617gwm1.wikievia.com/user